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Protein aggregation in the form of amyloid fibrils has important biological and technological
implications. Although the self-assembly process is highly efficient, aggregates not in the fibrillar
form would also occur and it is important to include these disordered species when discussing the
thermodynamic equilibrium behavior of the system. Here, we initiate such a task by considering a
mixture of monomeric proteins and the corresponding aggregates in the disordered form (micelles)
and in the fibrillar form (amyloid fibrils). Starting with a model on the respective binding free
energies for these species, we calculate their concentrations at thermal equilibrium. We then discuss
how the incorporation of the disordered structure furthers our understanding on the various amyloid
promoting factors observed empirically, and on the kinetics of fibrilization.
PACS numbers: 87.14.em, 82.35.Pq, 05.70.-a
I. INTRODUCTION
Amyloids are insoluble fibrous protein aggregations
stabilized by a network of hydrogen bonds and hydropho-
bic interactions [1, 2, 3, 4]. They are intimately re-
lated to many neurodegenerative diseases such as the
Alzheimer’s Disease, the Parkinson Disease and other
prion diseases [5]. Better characterization of the various
properties of amyloid fibrils is therefore of high impor-
tance for the understanding of the associated pathogen-
esis. More recently, viewing protein amyloid formation
as a highly efficient self-assembly process, possible appli-
cations have also been proposed. For instance, amyloid
fibrils have been employed as nanowire templates [6, 7],
were shown to possess great tensile strength [8, 9] and
complex phase behavior similar to liquid crystals [10, 11].
Given the high importance of protein amyloid in biol-
ogy and potentially in technology, it is being studied
intensively. In particular, much effort has been spent
on investigating the amino-acid dependency on amyloid
propensity [6, 12, 13, 14, 15, 16, 17]; the possibility of
primary-sequence-based amyloid propensity predictions
[18, 19, 20, 21, 22, 23]; the mechanical properties of pro-
tein amyloid [9, 24, 25]; the kinetics of amyloid forma-
tion [26, 27, 28, 29, 30, 31, 32, 33, 34]; as well as the
thermodynamical behaviours of the aggregation process
[35, 36, 37, 38].
Although the protein amyloid self-assembly process is
highly efficient, aggregates not in the fibrillar form would
also occur and it is important to include these disordered
species when discussing the thermodynamic equilibrium
behavior of the system. This motivates us to consider
here a system consisting of a mixture of monomers, ag-
gregates with a linearly ordered structure (fibrils) and
aggregates with a disordered structure (a micelle-like ag-
gregate) (c.f. Fig. 1). Starting with a discussion on their
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FIG. 1: (Color online) Schematic diagrams of the three species
considered in this paper: (a) a monomeric protein in solu-
tion; (b) a micelle, or an amorphous aggregate; (c) an eight-
monomer segment of an amyloid fibril consisting of two cross-
beta structures (one cross-beta structure is coloured, the other
is black). The hydrogen bonds stabilise the beta sheets in the
vertical direction (not shown in this figure). (Drawn with
DeepView [39].)
(a) (b) (c)
respective binding free energies, we deduce the concentra-
tions for the various species at thermal equilibrium, and
consider the experimental implications of our investiga-
tion. In particular, we study the effect of temperature
and pressure variations on the average fibrillar length.
We then discuss how our work relates to the empirically
observed variation in amyloid propensity with respect to
the primary sequences of the proteins. Finally, we em-
ploy the formalism developed to study the kinetic process
of aggregation.
The plan of the paper is as follows: In Section II, we
introduce our model of a amyloid-forming self-assembly
system. In Section III, we discuss the experimentally
relevant predictions from our model. In Section IV, we
consider how our findings relate to empirical observations
on amyloid propensity. In Section V, we investigate the
kinetic process of self-assembly from the perspective of
our free energy picture.
2II. THE MODEL
In this work, we are primarily concerned with amyloid
fibrilization of short peptides. Peptides interact via an
array of interactions, such as hydrophobic interactions,
hydrogen bonding, electrostatic interactions, etc (for a
review, see, e.g., [40, 41]). Due to these interactions,
aggregation may occur and we consider here two differ-
ent types of aggregates: i) linearly structured aggregates
(amyloid fibrils) and ii) disordered aggregates (micelles)
(c.f. Fig. 1). For the micellar species, we assume that
there is an optimal configuration consisting of M pro-
teins, where M is in the order of tens [62]. For the fib-
rillar species, we assume that the only ordered structure
is a two-tape structure, i.e., each fibril consists of stack-
ing two cross-beta structures (c.f. Fig. 1(c)). We note
that amyloid fibrils can exhibit structural variations even
when prepared under the same condition, and the precise
structural details will be highly primary sequence depen-
dent (see, e.g., [42]).
Now a note on terminology: we will call a free protein
in solution a monomer, and a fibril consisting of i pro-
teins a i-mer fibril. We will also denote from now on the
numbers of monomers, micelles and i-mer fibril in a solu-
tion of volume V by N (a), N (b) and N
(c)
i respectively. In
particular, if N denotes the total number of monomers,
we have
N (a) +MN (b) +
∑
i
iN
(c)
i = N . (1)
Given the three different species: monomers, micelles
and fibrils, we are interested in determining their respec-
tive volume fractions given an initial volume fraction C.
In this work, we will always set the unit of volume to
be the volume of one monomer. With this convention,
C = N/V where V is the volume of the system.
To calculate the relative abundances for the various
species, we firstly need to obtain their respective species-
specific Binding Free Energy (BFE). Without loss of gen-
erality, we will set the monomeric BFE to zero, and de-
note the micellar BFE by γ, where
γ = −T△sb +△ǫb + p△vb . (2)
In the above equation, △sa, △ǫb and △vb are the en-
tropic, binding energy and volumic differences between
the monomers and the micelles. In other words, △sb
quantifies the free energy contribution from the loss in
configurational freedom due to the rigidity of the aggre-
gates, △ǫb quantifies the change in internal energy re-
sulting from the various inter-protein and intra-protein
interactions, and △vb denotes the change in volume for a
monomer as a result of being part of a larger aggregate.
For the fibrillar species, we will denote the BFE of an
infinitely long fibril as:
f∞ = −T△sc +△ǫc + p△vc . (3)
The terms in the R.H.S. above have similar definitions
as in the micellar case aforementioned. For a finite-size
i-mer fibril, we will make the following assumption typ-
ically made in the study of linearly aggregating systems
(e.g., see [43]):
fi =
(
i− ξ
i
)
f∞ , (4)
where ξ (ξ > 0) accounts for the boundary effect at the
fibril’s ends and is of order one [43]. For instance, it
accounts for the loss of hydrophobic interactions at both
ends of a fibril.
With the BFE defined, we can calculate the concen-
trations of the various species by finding the minimum
of the total free energy of the system. We will start by
writing the total partition function as [44]:
Qtot =
′∏
i
(AV )N
(a)
(BV )N
(b)
(CiV )
N
(c)
i
N (a)! N (b)! N
(c)
i !
(5)
where, by the previous discussion on the BFE [63],
A = 1 (6)
B = exp(−Mγ/kBT ) (7)
Cj = exp[−(i− ξ)f∞/kBT ] . (8)
Note that the prime in the product in Eq. (5) denotes the
restriction that the total number of peptides is conserved
(c.f. Eq. (1)). The distribution of the various species
can now be obtained by determining the minimum of the
total free energy density,
Ftot = −kBT logQtot
V
, (9)
subject to the constraint shown in Eq. (1). This opti-
mization problem can be solved by the Lagrange multi-
plier method and the results are (see, e.g., [45]):
n(b) =
[
n(a)e−γ/kBT
]M
(10)
n
(c)
i =
[
n(a)e−(i−ξ)f∞/ikBT
]i
. (11)
The lower case n denotes the volume fraction of the cor-
responding species, i.e., n(.) ≡ N (.)/V .
For the micellar species, due to the magnitude of M
(M ≥ 10 [56]), if C < exp(γ/kBT ), the micellar volume
fraction will be negligible in comparison to the monomer
volume fraction; conversely, if C > exp(γ/kBT ), then the
monomeric volume fraction will be exp(γ/kBT ) and all
the excess monomers will be in the micellar form, i.e.,
n(b) ≃ C − exp(γ/kBT ) [43]. It is therefore legitimate to
define a critical concentration at Ccrit = exp(γ/kBT ).
We will call this the Critical Micellar Concentration
(CMC). For the fibrillar species, a similar reasoning in-
dicates that the critical concentration for fibrilization is
at Ccrit = exp(f∞/kBT ). We will call this the Critical
Fibrillar Concentration (CFC).
3If CMC < CFC and C ≫ CMC, CFC, almost all
monomers would be in the micellar form and the concen-
trations of monomers and fibrils are negligible by com-
parison. On the other hand, if C ≫ CFC,CMC and
CFC < CMC, then the concentrations of monomers and
micelles will be negligible while the concentration of the
fibrillar species will be abundant. In this fibril-dominant
regime, n
(c)
i follows the following distribution [43]:
n
(c)
i = exp[−i/L+ ξf∞/kBT ] (12)
where L is the average number of monomers in a fibril
such that
L ≡ 〈iN (c)i 〉 =
√
Ce−ξf∞/kBT . (13)
Since a fibril is a linear structure, the average fibrillar
length is thus proportional to L. According to Eq. (13),
the average fibril length scales with
√
C. This fact is ob-
served in other linear aggregating systems and is a mani-
festation of the one-dimensional nature of the aggregates
[43, 46]. The profile of i × n(c)i versus i is depicted in
the inset plot in Fig. 2. This analytical result is quali-
tatively confirmed by the experimental observations on
β-lactoglobulin amyloid fibrils [47, 48].
We will now try to estimate the magnitudes of the
terms appearing in Eq. (3). For the first term, let us
assume that a protein in monomeric form is in the de-
natured state, and a fibrilized protein corresponds to the
folded state. It has been experimentally and theoretically
estimated that, by going from the denatured state to the
folded state, a protein loses on average around kB ln 10
per amino acid in entropy [40, 49, 50]. We will therefore
estimate △sc as −RkB ln 10 = −2.3 × RkB where R is
the number of amino acids in the protein . For the third
term in Eq. (3), it has been demonstrated that the change
in the protein’s volume upon folding is very small [51].
Indeed, it is found that the change in volume per amino
acid upon folding is in the order of 0.01 nm3 [51], which
suggests that p△vc ∼ 0.07×RkBT at atmospheric pres-
sure. It is therefore negligible in comparison to the en-
tropic contribution. The second term in Eq. (3) involves
a combination of interactions, such as hydrogen bond-
ing, hydrophobic interactions, electrostatic interactions,
etc, among which hydrophobic interactions, which are of
the order of a few kBT per amino acid, are believed to
be dominant [41, 52]. Since hydrophobic interactions in-
volves effective burying of hydrophobic side-chains inside
the protein structure, it indicates the need for a multi-
layered fibrillar structure (such as our two-tape model
employed here), as universally observed in amyloid fib-
rils formed from different proteins [4].
III. EXPERIMENTAL IMPLICATIONS
We will now focus on the fibrillar phase, i.e., we are in
the scenario where C > CFC and CFC < CMC. Accord-
FIG. 2: (Color online) Dominance diagram of the three-
species system at concentration higher than the critical con-
centrations: CMC and CFC. The coloured arrows depict how
the dominance may shift under increase in hydrophobicity
(red), increase in the number of aromatic side chains (blue),
increase in alternating hydrophobic-hydrophilic amino-acid
sequence (green), and increase in unpaired charges in the
side chains (black). Inset plot: The volume fractions of i-
mer fibrils versus i in the fibrillar phase (i.e., C ≫ CFC and
CMC > CFC), where L ≡ 〈iN
(c)
i 〉 is set to be 500.
ing to Eq. (13):
lnL = − ξf∞
2kBT
+
1
2
lnC . (14)
If we equate a monomeric protein to a denatured pro-
tein, and a fibrilized protein to a folded protein, then
experimental work indicates that f∞/T is a concave up
function with respect to T such that the minimum occurs
at around 20◦C [53, 54]. This suggests that in an isobaric
experiment, the average fibril length would first increase
and then decrease as temperature increases.
The situation for pressure variation is more compli-
cated due to the fact that the compressibility differs for
different amino acids. Nevertheless, it has been found
generally that at low pressure (∼ 1 atm), the change in
volume upon folding is small while the change is pos-
itive at very high pressure (7500 atm [55]) due to the
fact that denatured protein has greater compressibility
[51, 56]. In other words, if we again equate a monomeric
protein to a denatured protein, and a fibrilized protein to
a folded protein, we would expect that, in the very high
pressure regime, an increase in pressure would lead to an
exponential decrease in the average fibrillar length in an
isothermal experiments.
4IV. RELEVANCE TO PREVIOUS EMPIRICAL
FINDINGS
As discussed in Sect. II, if C ≫ CMC,CFC, the dom-
inant species in the system will be the one with a lower
critical concentration. Namely, in terms of BFE, the
dominant species will be fibrillar if f∞ < γ, and vice
versa. We will now discuss how the primary sequence
may affect amyloid propensity in terms of the BFE. To
simplify the discussion, we will assume that substituting
an amino acid affects predominantly the binding energy
term, △ǫ, in the BFE (c.f. Fig. 2).
As a result of empirical observations [18, 19, 20, 21,
22, 23], it is generally agreed that the following fac-
tors promote amyloid formation: i) an increase in hy-
drophobicity, and ii) an increase in length of an alternat-
ing hydrophobic-hydrophilic amino-acid sequence; while
it is found that an increase in the number of charged
amino acids decreases amyloid propensity. In terms of
the binding energies, an increase in hydrophobicity would
decrease both△ǫb and△ǫc and as such would on average
increase the fibrilization probability if the protein’s pa-
rameters are already close to the monomer-fibril bound-
ary in the dominance diagram (the red arrow in the
Fig. 2). For our two-tape model for the amyloid fibril
(c.f. Fig. 1(c)), an increase in alternating hydrophobic-
hydrophilic amino-acid sequence would allow for packing
the hydrophobic side chains inside the cross-beta sheet
structure, while having the hydrophilic side chains out-
side, this would decrease△ǫc. On the other hand, having
such a pattern would conceivably decrease the average
energy gained inside a micellar structure given the amor-
phous structural nature, i.e., △ǫb will be increased. Such
a modification would therefore increase amyloid propen-
sity (the green arrow in the Fig. 2). If there is an in-
crease in paired charges in the protein, i.e., charges that
are not accompanied by ionic bonds, electrostatic inter-
action would deter aggregation and as such both△ǫb and
△ǫc will be increased (the black arrow in the Fig. 2).
Another insight we can gain from the above consid-
eration concerns the importance of aromatic residues in
amyloid propensity [6, 12, 13, 14, 15, 16, 17]. Beside
the heightened hydrophobicity in aromatic residues, the
offsetted π-stacking interaction is directional along the
fibrillar axis [58, 59], hence ǫc may be decreased more
than ǫb (the blue arrow in the Fig. 2). This suggests
that aromatic interaction, or any interactions directional
along the fibrillar axis, contributes to amyloid stability in
a way different from ordinary hydrophobic interactions.
V. KINETICS
We discuss now how the picture developed in this pa-
per helps to describe the kinetics of the protein amyloid
self-assembly process investigated experimentally. Ac-
cording to the model proposed in [57], the series of events
leading up to the fibrilization of amyloid-β proteins is de-
FIG. 3: (Color online) (a) A schematic digram depicting the
amyloid-beta self-assembly process proposed in [57]. The cir-
cle denotes the free monomeric state, the square denotes the
typical micellar state (the micellar size, M , is estimated to be
25 [57]), and the triangle denotes a stable nucleus (the nucleus
size is estimated to be 10 [57]). The thick arrow depicts the
fast pathway from free monomer to micelles and the thin ar-
row depicts the slow process of nucleation from micelles. The
broken arrow depicts that very slow process of nucleation from
free monomers, which is out of the range of experimental time
scale, but may play an important role in actual pathogenesis
under physiological time scale. (b) The temporal evolution of
monomer concentration. Upper plot: When C > CMC, the
monomers are quickly converted into micelles and then slowly
into fibrils. The figures above the curve depict the dominant
species in the solution as time progresses. Lower plot: When
CFC < C < CMC, the proteins remain in monomeric form
for a time longer than can be probed experimentally. These
two plots show the curious phenomenon of the possibility of
ending up with a lower monomeric concentration when the
initial concentration is higher.
picted in Fig. 3. In this scenario, the direct pathway from
monomers to stable nucleus (depicted by the broken ar-
row in Fig. 3) is in a time scale too long to be probed
experimentally. Therefore, the only possible fibrilization
pathway is for the monomers to first formed micelles (a
fast process, depicted by the thick black arrow), stable
nuclei are then formed out of the micelles (a slow pro-
cess, depicted by the thin black arrow). Based on this
model, within the temporal constraint of experiments,
fibrilization is only possible if C > CMC (c.f. Fig. 3(b)).
In the case of the amyloid-β protein, the CMC has been
measured to be in the order of 10 µM [60]. This is sub-
stantially higher than the concentration of amyloid-beta
in the cerebral spinal fluid, which is in the subnanomolar
concentration range [61]. It therefore poses the question
are current experimental methods only probing the fast
pathway – monomers to micelles to nucleus (depicted by
the two solid arrows), while the physiologically relevant
pathway is the slow pathway – monomers to nucleus (de-
picted by the broken arrow).
5VI. CONCLUSION
In this work, we have considered the thermodynamic
equilibrium behavior of a system with a mixture of
monomeric proteins, the corresponding micellar aggre-
gates and fibrillar aggregates. We have deduced the con-
centrations of these species at thermal equilibrium and
we have found that the average fibrillar length is very
sensitive to temperature or pressure variation. We have
also discussed the relevance of our investigation to pre-
vious empirical findings and to the understanding of the
kinetical process of fibrilization.
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